| Pharmaceutical Information |
| Drug Name |
Fluticasone furoate |
| Drug ID |
BADD_D00946 |
| Description |
Fluticasone furoate is a synthetic glucocorticoid available as an inhaler and nasal spray for various inflammatory indications[FDA Label][F4364]. Fluticasone furoate was first approved in 2007[L5965]. |
| Indications and Usage |
Fluticasone furoate is indicated as an inhaler for the treatment and management of asthma by prophylaxis[FDA Label][F4364]. The fluticasone furoate nasal spray is indicated for treating season and perennial allergic rhinitis[FDA Label][A177130]. |
| Marketing Status |
approved |
| ATC Code |
R01AD12; R03BA09 |
| DrugBank ID |
DB08906
|
| KEGG ID |
D06315
|
| MeSH ID |
C523187
|
| PubChem ID |
9854489
|
| TTD Drug ID |
D0Y7JU
|
| NDC Product Code |
47848-057; 64918-1915; 0135-0615; 64918-1910; 64918-1916; 22552-0042; 63379-083; 55018-302; 58175-0553; 0135-0616; 63592-3370; 0173-0874; 0173-0888; 50090-5967; 49076-6452; 59057-010; 0173-0876; 50090-6075; 15308-2021; 52482-008; 63379-084; 49076-6451; 59057-009; 64918-1117 |
| UNII |
JS86977WNV
|
| Synonyms |
fluticasone furoate |
|
| Chemical Information |
| Molecular Formula |
C27H29F3O6S |
| CAS Registry Number |
397864-44-7 |
| SMILES |
CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
